SME Forwarders Must Specialize to Compete in Pharma Logistics

Pharma.Aero's secretary general Frank van Gelder has issued a clear strategic directive to small and medium-sized forwarding companies: entering pharmaceutical logistics requires deep specialization, not simply pursuing margin opportunities. The pharmaceutical sector presents genuine growth opportunities driven by clinical trials, time-critical healthcare shipments, and emerging advanced therapies, but SMEs must build demonstrable expertise, validated procedures, and temperature-control competence to succeed. Van Gelder emphasizes that competing on price alone is a losing strategy in pharma logistics.

Instead, successful SME forwarders should focus on regional corridors, high-touch services near research centers and hospitals, and leveraging local knowledge combined with trusted international partnerships. He warns that GDP compliance certification alone does not demonstrate understanding of divergent pharmaceutical product categories: conventional medicines, clinical trials, and personalized therapies each present fundamentally different operational requirements. The article highlights a critical insight for supply chain professionals: organizational agility matters less than disciplined systems combined with empowered teams.

Smaller operators can compete effectively by responding faster to disruption through workforce resilience and decision-making authority, but this advantage only materializes when built on a foundation of systems quality, specialist knowledge, and reliable partnerships. The future of pharma logistics belongs not to companies with the largest networks, but to those capable of orchestrating the most dependable supply chains.